Lineage Cell Therapeutics is a clinical-stage biotech developing 'off-the-shelf' allogeneic cell therapies using its proprietary AlloSCOPE platform. The company creates specialized human cells through directed differentiation of pluripotent cell lines and transplants them into patients to replace or support cells lost to degenerative disease, aging, or injury. Lead programs include OpRegen for dry AMD and OPC1 for spinal cord injury.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountJan 2022
Jan 2021
Jan 2020
Create a free account to see which investors have funded this company.
Create Free Account
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...
Health insurance company using technology to make health care simple, affordable, and accessible.
Global clinical research organization specializing in early-stage clinical trials and bioanalytic...
